Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one

被引：17

作者：

Velaparthi, Upender ^{[1
]}

Saulnier, Mark G. ^{[1
]}

Wittman, Mark D. ^{[1
]}

Liu, Peiying ^{[1
]}

Frennesson, David B. ^{[1
]}

Zimmermann, Kurt ^{[1
]}

Carboni, Joan M. ^{[4
]}

Gottardis, Marco ^{[4
]}

Li, Aixin ^{[4
]}

Greer, Ann ^{[4
]}

Clarke, Wendy ^{[2
]}

Yang, Zheng ^{[3
]}

Menard, Krista ^{[4
]}

Lee, Francis Y. ^{[4
]}

Trainor, George ^{[4
]}

Vyas, Dolatrai ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Dept Discovery Chem, Wallingford, CT 06492 USA

[2] Bristol Myers Squibb Co, Dept Metab & Pharmacokinet, Wallingford, CT 06492 USA

[3] Bristol Myers Squibb Co, Dept Metab & Pharmacokinet, Princeton, NJ 08543 USA

[4] Bristol Myers Squibb Co, Dept Oncol Drug Discovery, Princeton, NJ 08543 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 10期

关键词：

Insulin-like growth factor-1 receptor (IGF-1R); Kinases; IGF; Benzimidazole; Piperazine; CYP3A4; inhibition; Solubility; VIVO ANTITUMOR-ACTIVITY; DISCOVERY; BMS-536924;

D O I：

10.1016/j.bmcl.2010.03.057

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of 3-[6-(4-substitued-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one were synthesized to modulate CYP3A4 inhibition and improve aqueous solubility of our prototypical compound BMS-536924 (1), while maintaining potent IGF-1R inhibitory activity. Structure-activity and structure-solubility studies led to the identification of BMS-577098 (27), which demonstrates oral in vivo efficacy in animal models. The improvement was achieved by replacing morpholine with more polar bio-isoster piperazine and modulating the basicity of distal nitrogen with appropriate substitutions. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：3182 / 3185

页数：4

共 50 条

[31] 3-(1-Adamantyl)-1-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-4-methyl-1H-1,2,4-triazole-5(4H)-thione
Al-Tamimi, Abdul-Malek S.
Bari, Ahmed
Al-Omar, Mohamed A.
Alrashood, Khalid A.
El-Emam, Ali A.
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O1756 - U175
[32] 6-(3,5-Dimethyl-1H-pyrazol-1-yl)1,2,4,5-tetrazin-3(2H)-one
Suponitsky, Kyrill Yu.
Chernyshev, Victor M.
Mazharova, Anna G.
Palysaeva, Nadezhda V.
Sheremetev, Aleksei B.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O1630 - +
[33] 3-(Adamantan-1-yl)-4-methyl-1-({4-[3( trifluoromethyl) phenyl] piperazin-1-yl}methyl)- 4,5-dihydro-1H-1,2,4-triazole-5thione
El-Emam, Ali A.
Al-Tamimi, Abdul-Malek S.
Alrashood, Khalid A.
Ng, Seik Weng
Tiekink, Edward R. T.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O695 - +
[34] N-[1-(1H-Benzimidazol-2-yl)-2-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)vinyl]benzamide
Kaushik, Darpan
Maan, Namita
MOLBANK, 2011, (03)
[35] 3-[(R)-1-Hydroxybutan-2-yl]-1,2,3-benzotriazin-4(3H)-one
Rocha-Alonzo, Fernando
Morales-Morales, David
Hernandez-Ortega, Simon
Reyes-Martinez, Reyna
Parra-Hake, Miguel
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O3240 - +
[36] Bis[2-(1-methyl-1H-imidazol-2-yl-3-iosulfanyl)-6-(1-methyl-1H-imidazol-2-ylsulfanyl)pyridine] tetrachloroferrate tetrafluoroborate
Lewis, GR
Hubberstey, P
Sampson, CL
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2002, 58 : M331 - M333
[37] Crystal structure of (E)-3-(3-(5-methyl-1-4-tolyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)-1-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)prop-2-en-1-one, C31H26N8O
Alotaibi, Mohammad Hayal
Mohamed, Hanan A.
Abdel-Wahab, Bakr F.
Abu El-Enin, Mohammed Abu Bakr
Ghabbour, Hazem A.
El-Hiti, Gamal A.
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2018, 233 (04): : 647 - 648
[38] Synthesis of {4-[1-(2-Fluorophenyl)-1H-thieno[3,2-c]pyrazol-3-yl]piperazin-1-yl}(1-methyl-1H-imidazol-4-yl)methanone
Thoomuganti, R. D.
Maringanti, T. C.
Ananthoju, K. K.
Eppakayala, L.
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2023, 59 (03) : 548 - 551
[39] Synthesis of {4-[1-(2-Fluorophenyl)-1H-thieno[3,2-c]pyrazol-3-yl]piperazin-1-yl}(1-methyl-1H-imidazol-4-yl)methanone
R. D. Thoomuganti
T. C. Maringanti
K. K. Ananthoju
L. Eppakayala
Russian Journal of Organic Chemistry, 2023, 59 : 548 - 551
[40] 2-(Morpholin-4-yl)-6-(1H-pyrrol-1-yl)pyridine-3,5-dicarbonitrile
Horton, Peter N.
Mohamed, Shaaban K.
Soliman, Ahmed M.
Abdel-Raheem, Eman M. M.
Akkurt, Mehmet
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O885 - U3288

← 1 2 3 4 5 →